Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection

OBJECTIVES: This study investigated how different concentrations of doxorubicin (DOX) can affect the function of cardiac cells. This study also examined whether activation of prokineticin receptor (PKR)-1 by a nonpeptide agonist, IS20, prevents DOX-induced cardiovascular toxicity in mouse models. BA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasser, Adeline, Chen, Yu-Wen, Audebrand, Anais, Daglayan, Ayhan, Charavin, Marine, Escoubet, Brigitte, Karpov, Pavel, Tetko, Igor, Chan, Michael W.Y., Cardinale, Daniela, Désaubry, Laurent, Nebigil, Canan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352030/
https://www.ncbi.nlm.nih.gov/pubmed/34396166
http://dx.doi.org/10.1016/j.jaccao.2019.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352030/
https://www.ncbi.nlm.nih.gov/pubmed/34396166
http://dx.doi.org/10.1016/j.jaccao.2019.06.003

Ejemplares similares